AdaptHealth Corp. AHCO
Set alert
5.91 USD +0.10 +1.72%
At close
5.86 -0.05 -0.83%
Pre-market · Nov 3, 4:01 AM ET
5.76 Day range 6.01
5.21 52-week range 13.43
- YTD
- -40.66%
- 1 year
- -34.98%
- Open
- 5.81
- Prev close
- 5.81
- Mkt cap
- 804.08M
- Vol
- 3.04M
- Avg vol
- 3.16M
- EPS
- -1.82
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.76
- High
- 6.01
- Forward P/E
- 12.22
- Beta
- 1.45
- Short ratio
- 0.00
- Inst. own
- 106.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 10.55
- 200-d avg
- 10.26
- 1y target
- 13.63
Analyst view
Consensus: buy
Buy
Price target (mean) 13.63
Ratings (0m) 8 6 buy · 2 hold · 0 sell
- Strong buy5
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
8 analysts give a price target
- This month 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.1454 | 0.0326 – 0.25 | 0.0712 | +104.3% | 848.59M | +6.0% | 6 |
| Current quarter | 0.0117 | -0.02 – 0.04 | 0.0239 | -51.1% | 796.63M | +2.4% | 6 |
| Current quarter | 0.2393 | 0.1857 – 0.29 | 0.22 | +8.8% | 799.31M | -0.8% | 6 |
| Current quarter | 0.1582 | 0.1091 – 0.19 | 0.2153 | -26.5% | 803.80M | -0.3% | 6 |
| Current quarter | 0.04 | -0.03 – 0.12 | 0.1535 | -73.9% | 764.77M | -3.5% | 5 |
| Current quarter | 0.17 | 0.12 – 0.20 | -3.43 | +105.0% | 809.30M | +0.7% | 5 |
| Current quarter | 0.16 | 0.04 – 0.21 | 0.09 | +77.8% | 802.62M | +1.2% | 5 |
| Current quarter | 0.05 | -0.03 – 0.09 | 0.11 | -54.5% | 769.87M | +3.4% | 7 |
| Current quarter | 0.20 | 0.14 – 0.28 | 0.11 | +81.8% | 796.60M | +7.9% | 7 |
| Current quarter | 0.10 | 0.05 – 0.19 | 0.09 | +11.1% | 765.20M | +5.2% | 6 |
| Current quarter | 0.08 | 0.02 – 0.12 | 0.30 | -73.3% | 756.45M | +7.1% | 7 |
| Current quarter | 0.31 | 0.25 – 0.39 | 0.20 | +55.0% | 737.94M | 0.0% | 7 |
| Current quarter | 0.26 | 0.20 – 0.36 | 0.12 | +116.7% | 724.22M | +26.2% | 8 |
| Current quarter | 0.18 | 0.12 – 0.30 | -0.04 | +550.0% | 651.46M | +35.1% | 7 |
| Current quarter | 0.28 | 0.17 – 0.37 | -0.04 | +800.0% | 637.68M | 0.0% | 5 |
| Current quarter | 0.21 | 0.02 – 0.30 | 0.08 | +162.5% | 617.02M | 0.0% | 6 |
| Current quarter | 0.23 | 0.11 – 0.32 | 0.00 | 0.0% | 486.34M | +154.0% | 8 |
| Current quarter | 0.12 | 0.08 – 0.24 | 0.00 | 0.0% | 265.31M | 0.0% | 6 |
| Current quarter | 0.19 | 0.08 – 0.31 | 0.00 | 0.0% | 196.28M | 0.0% | 3 |
| Current quarter | 0.12 | 0.04 – 0.21 | 0.00 | 0.0% | 177.40M | 0.0% | 3 |
| Next quarter | 0.3188 | 0.2131 – 0.45 | 0.2334 | +36.6% | 886.65M | +8.1% | 6 |
| Current year | 0.8407 | 0.5844 – 1.11 | 0.5428 | +54.9% | 3.49B | +7.5% | 6 |
| Current year | 0.713 | 0.65 – 0.78 | 0.9789 | -27.2% | 3.23B | -0.9% | 6 |
| Current year | 0.9201 | 0.82 – 1.00 | 1.06 | -13.5% | 3.23B | +1.0% | 5 |
| Current year | -2.35 | -3.27 – 0.85 | 0.33 | -812.1% | 3.17B | +6.6% | 5 |
| Current year | 0.78 | 0.72 – 0.85 | 0.67 | +16.4% | 2.98B | +21.3% | 5 |
| Current year | 1.12 | 0.70 – 1.41 | -1.23 | +191.1% | 2.44B | +130.9% | 3 |
| Current year | 0.23 | 0.14 – 0.33 | -0.66 | +134.8% | 1.03B | +94.6% | 4 |
| Current year | 0.09 | -0.31 – 0.51 | 0.00 | 0.0% | 522.33M | 0.0% | 4 |
| Next year | 1.17 | 0.82 – 1.49 | 0.8407 | +39.7% | 3.71B | +6.5% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 6, 2026 | Baird | Maintained | Outperform | Outperform |
| May 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | UBS | Maintained | Buy | Buy |
| Apr 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| Feb 26, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Nov 6, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 12, 2025 | Truist Securities | Maintained | Buy | Buy |
| May 8, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 27, 2025 | Baird | Maintained | Outperform | Outperform |
| Feb 26, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 26, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 26, 2025 | Truist Securities | Maintained | Buy | Buy |
| Feb 13, 2025 | UBS | Maintained | Buy | Buy |
| Nov 19, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Nov 6, 2024 | UBS | Maintained | Buy | Buy |
| Nov 6, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 6, 2024 | Baird | Maintained | Outperform | Outperform |
| Aug 12, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| May 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Mar 4, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Feb 28, 2024 | UBS | Maintained | Buy | Buy |
| Feb 28, 2024 | Truist Securities | Maintained | Buy | Buy |
| Jan 29, 2024 | UBS | Maintained | Buy | Buy |
| Nov 8, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 8, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Nov 8, 2023 | Truist Securities | Maintained | Buy | Buy |
| Oct 11, 2023 | Truist Securities | Maintained | Buy | Buy |
| Sep 22, 2023 | B of A Securities | Maintained | Neutral | Neutral |